investorscraft@gmail.com

Intrinsic Value of Lion Corporation (4912.T)

Previous Close¥1,465.50
Intrinsic Value
Upside potential
Previous Close
¥1,465.50

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Lion Corporation operates as a diversified consumer goods company with a strong presence in Japan and select international markets. Its core segments—Consumer Products, Industrial Products, and Overseas Business—span oral care, personal hygiene, household cleaners, and specialty chemicals. The company leverages its century-old heritage to maintain brand trust, particularly in dental care, where it holds a competitive edge through innovation in formulations like periodontitis treatments. Its industrial division supplies niche chemicals for construction and manufacturing, adding stability to revenue streams. Lion’s vertically integrated production and distribution network enhances cost efficiency, while its focus on health-centric products aligns with Japan’s aging demographics and global wellness trends. Despite competition from multinationals like P&G and Unilever, Lion’s regional expertise and product localization sustain its market share.

Revenue Profitability And Efficiency

Lion reported revenue of ¥412.9 billion for FY2024, with net income of ¥21.2 billion, reflecting a 5.1% net margin. Operating cash flow stood at ¥43.7 billion, though capital expenditures of ¥18.1 billion indicate ongoing investments in production capacity. The company’s asset-light model and focus on high-margin segments like oral care contribute to steady profitability.

Earnings Power And Capital Efficiency

Diluted EPS of ¥76.41 underscores Lion’s earnings stability, supported by recurring demand for essential consumer goods. The firm’s capital efficiency is evident in its low debt-to-equity ratio and disciplined reinvestment strategy, prioritizing R&D (e.g., dermatologic agents) and market expansion in Asia.

Balance Sheet And Financial Health

Lion maintains a robust balance sheet with ¥102.2 billion in cash and equivalents against ¥29.7 billion in total debt, ensuring liquidity. Its conservative leverage profile and strong cash reserves provide flexibility for strategic acquisitions or dividend growth.

Growth Trends And Dividend Policy

Revenue growth has been modest, in line with Japan’s stagnant consumer market, but overseas expansion (e.g., health supplements in Southeast Asia) offers upside. The dividend payout of ¥27 per share reflects a sustainable ~35% payout ratio, appealing to income-focused investors.

Valuation And Market Expectations

At a market cap of ¥427.2 billion, Lion trades at ~20x trailing earnings, a premium to peers, likely pricing in its defensive qualities and brand equity. Low beta (0.002) signals resilience to market volatility.

Strategic Advantages And Outlook

Lion’s dual focus on consumer staples and industrial chemicals mitigates cyclical risks. Near-term challenges include input cost inflation, but its R&D pipeline (e.g., plant-based insulating oils) and aging-population tailwinds support long-term relevance.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount